Neogenomics (NEO) P/E (2011 - 2026)
Neogenomics (NEO) P/E from Mar 31, 2011 to Jul 21, 2026. The TTM Neogenomics (NEO) P/E is -3.44. You can export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
P/E
Annual P/E change of Neogenomics (NEO)
| Year | P/E | Change |
|---|---|---|
| 2026 | -3.44 | +22.87% |
| 2025 | -2.80 | -47.67% |
| 2024 | -5.35 | +25.31% |
| 2023 | -4.27 | +201.51% |
| 2022 | -1.42 | -98.50% |
| 2021 | -94.63 | -128.69% |
| 2020 | 329.87 | +319.79% |
| 2019 | 78.58 | -10.52% |
| 2018 | 87.82 | -876.56% |
| 2017 | -11.31 | -91.46% |
| 2016 | -132.47 | +210.90% |
| 2015 | -42.61 | -202.22% |
| 2014 | 41.69 | +15.07% |
| 2013 | 36.23 | -44.58% |
| 2012 | 65.36 | -890.03% |
| 2011 | -8.27 | N/A |
Comparison Neogenomics (NEO) P/E with competitors
Neogenomics (NEO) P/E is -3.44.
| Ticker | Name | P/E | Upside |
|---|---|---|---|
| ADVB | Advanced Biomed Inc | 1.05 | -130.47% |
| MBAI | CheckCap Ltd | 1.71 | -149.78% |
| FONR | Fonar Corp | 15.48 | -549.85% |
| QGEN | Qiagen NV | 20.03 | -682.13% |
| DGX | Quest Diagnostics Inc | 22.47 | -753.15% |
| LH | Laboratory Corp Of America Holdings | 23.87 | -793.77% |
| IQV | IQVIA Holdings Inc | 25.28 | -834.80% |
| A | Agilent Technologies Inc | 26.96 | -883.49% |
| TMO | Thermo Fisher Scientific Inc | 31.53 | -1016.33% |
| MTD | Mettler-Toledo International Inc | 32.45 | -1043.12% |
| MEDP | Medpace Holdings Inc | 32.55 | -1046.01% |
| DHR | Danaher Corp | 38.55 | -1220.49% |
| IDXX | Idexx Laboratories Inc | 40.58 | -1279.25% |
| ILMN | Illumina Inc | 44.12 | -1382.26% |
| RVTY | Revvity Inc | 52.68 | -1631.08% |
| VCYT | Veracyte Inc | 53.71 | -1661.04% |
| ICLR | Icon Plc | 57.45 | -1769.72% |
| SHC | Sotera Health Company | 74.08 | -2253.13% |
| WAT | Waters Corp | 102.79 | -3087.29% |